Le invitamos a participar en este exclusivo encuentro que reunirá a expertos y líderes clínicos para explorar los avances más recientes en medicina de precisión y genómica aplicada.

El evento contará con la participación del Presidente de SOPHiA GENETICS, quien compartirá la visión global de la compañía, así como con especialistas que abordarán el impacto de NGS en hemato-oncología y las tendencias futuras del área.

Asimismo, el evento destacará experiencias reales de clientes que compartirán su práctica clínica utilizando la plataforma SOPHiA DDM™, ofreciendo una perspectiva concreta sobre su impacto en el diagnóstico y la toma de decisiones.

A continuación, encontrará la agenda preliminar del evento.

What: SOPHiA GENETICS Exclusive Networking event

Where: Savoy Hotel

Date: 21 de abril

Time: 19:00 - 22:00

Agenda

Why Attend?

Discover SOPHiA DDM™ – One platform, universally compatible, endless possibilities

Discover how SOPHiA DDM™ enables accurate analysis across multiple disease areas – from oncology to inherited disorders

Tackle practical challenges

Discuss the future of research and healthcare institutions to harness NGS data for quick, robust, and actionable insights, guiding best decisions.

Network with thought leaders

Connect with your peers and enjoy a networking environment with your peers and users of SOPHiA DDM™ Platform

El GENOMiCS INSIGHTS Day Bogotá se llevará a cabo el próximo 23 de abril, en el Hotel W Bogotá.

Este encuentro reunirá a expertos, líderes clínicos y profesionales del área de la genómica para explorar los avances más recientes en medicina de precisión y el impacto creciente de las tecnologías genómicas en la práctica clínica.

Durante la jornada abordaremos temas clave como la visión global de innovación de SOPHiA GENETICS, las nuevas posibilidades clínicas de la biopsia líquida, experiencias reales de implementación en la práctica clínica con la plataforma SOPHiA DDM™, y nuevas oportunidades para ampliar el análisis genómico mediante exomas optimizados.

Este espacio también busca fomentar el intercambio de experiencias y la conversación entre profesionales del sector, promoviendo el avance de la medicina genómica en la región.

A continuación, encontrará la agenda preliminar del evento.

What: SOPHiA GENETICS Exclusive Networking event

Where: Hotel W Bogotá

Date: 23 de abril

Time: 16:00 - 19:00

Agenda

Why Attend?

Discover SOPHiA DDM™ – One platform, universally compatible, endless possibilities

Discover how SOPHiA DDM™ enables accurate analysis across multiple disease areas – from oncology to inherited disorders

Tackle practical challenges

Discuss the future of research and healthcare institutions to harness NGS data for quick, robust, and actionable insights, guiding best decisions.

Network with thought leaders

Connect with your peers and enjoy a networking environment with your peers and users of SOPHiA DDM™ Platform

En el marco del Día Internacional de la Mujer, este webinar presentará la trayectoria académica y profesional de la Dra. Carmen Alaez, reconocida líder en el campo de la genómica en América Latina. La sesión abordará los desafíos asociados a la implementación de metodologías avanzadas en el laboratorio clínico, así como el proceso de consolidación de la secuenciación de próxima generación como herramienta estratégica para el diagnóstico de enfermedades raras.

Se analizarán también los retos específicos del contexto latinoamericano, como: el acceso a tecnologías y fortalecimiento de capacidades diagnósticas, así como también estos han sido enfrentados y superados a lo largo de los años. La Dra. Alaez profundizará en estos desafíos, compartiendo una visión integral de su trayectoria en genómica del cáncer hereditario y diagnóstico molecular, así como del liderazgo femenino en el desarrollo de la medicina genómica en la región.

Ponente:
Dra. Carmen Alaez
Jefe de Departamento de Diagnóstico Genómico
INMEGEN, Mexico

Doctora en Ciencias Químicobiológicas por el IPN, es Investigadora en Ciencias Médicas “C” y Jefa del Laboratorio de Diagnóstico Genómico del INMEGEN, miembro del SNII Nivel II. Desde 2015 lidera investigaciones en genómica del cáncer y diagnóstico de enfermedades hereditarias, con enfoque en cáncer de mama y ovario, tumores sólidos, leucemia pediátrica y enfermedades mendelianas. Cuenta con 75 publicaciones, 28 capítulos de libro y cerca de 875 citas. Ha dirigido 15 tesis y ha recibido 39 premios y distinciones.

Hora:
10:00 AM (Mexico)
11:00 AM (Colombia)
1:00 PM (Brazil / Argentina)

Melania Abreu González, MD/MS 
Clinical Geneticist & Co-Founder, Genos Médica (Mexico) 

Chronic lymphocytic leukemia (CLL) is the most common leukemia in adults across Western countries, but its incidence in Latin America is 3–5× lower, with some of the lowest rates observed in regions with high Amerindian ancestry. In Mexico, CLL represents only 7% of leukemia cases in Mestizo populations, making comprehensive molecular insights rare and highly valuable. 

In this focused on-demand session, Dr. Abreu shares new learnings from targeted NGS analysis in the low-prevalence Mexican population and discusses how modern tools can reshape CLL assessment, stratification, and accelerate decision-making. 

What You’ll Learn 

• CLL’s molecular and clinical heterogeneity 
  Why predicting outcomes remains challenging and how genetic alterations shape prognosis and therapy. 
• The value of NGS for CLL analysis 
  Consolidated detection of SNVs, Indels, CNVs, and IGHV status; improved visibility of clonal populations; and enhanced cost efficiency with batch processing; seamless integration with IgCaller for immunoglobulin rearrangement characterization. 
• Practical workflow advantages 
  How a single, scalable NGS application can: 
  – Improve efficiency 
  – Support earlier risk stratification 
  – Maintain high-quality variant characterization while reducing overall costs 

Why Watch? 

Get clear, real-world guidance on optimizing CLL workflows and generating meaningful insights in populations where data is limited. 

We’re proud to welcome the Instituto Nacional de Cancerología (INCAN) of Mexico to the SOPHiA GENETICS community.

As Mexico’s leading national cancer institute, INCAN plays a vital role in advancing cancer prevention, research, and education across the country. By leveraging SOPHiA DDM™ Hereditary Cancer Solution, INCAN researchers can deepen their understanding of the complex landscape of hereditary cancer disorders and contribute to the development of data-driven approaches that advance precision medicine in Latin America.

At SOPHiA GENETICS, our mission is to empower institutions like INCAN with technology that transforms complex genomic data into meaningful insights. Together, we’re helping accelerate the future of oncology research, one discovery at a time.

🔗 Learn more about our Hereditary Cancer Solution: https://www.sophiagenetics.com/sophia-ddm-for-genomics/hereditary-cancers/

We’re excited to celebrate Genos Médica, a leader in genetic and genomic medicine in Mexico, as they expand their collaboration with SOPHiA GENETICS to further their research using the SOPHiA DDM™ Platform.

Genos Médica is adopting SOPHiA DDM™ Exhanced Whole Exome and Liquid Biopsy applications to strengthen its research capabilities in rare disease and oncology, empowering its teams to uncover new insights that support the growth of precision medicine across Mexico and Latin America.

“Our collaboration withSOPHiA GENETICS allows us to explore the full potential of genomic data through cutting-edge applications like whole exome and liquid biopsy. These technologies will help advance our research efforts and expand the understanding of genetic variation in diverse populations.” said Dr. Melania Abreu González, Medical Geneticist, Genos Médica

At SOPHiA GENETICS, we’re proud to partner with research and clinical institutions worldwide that share our vision: democratizing data-driven medicine and accelerating discovery for a healthier future.

🔗 Learn more about our enhanced exome solutions here: https://www.sophiagenetics.com/sophia-ddm-for-genomics/inherited-disorders/sophia-ddm-enhanced-exome-solutions

We’re thrilled to welcome Seguros SURA Colombia to the SOPHiA GENETICS community as they adopt MSK-ACCESS® powered by SOPHiA DDM™ to advance their precision oncology research initiatives.

As one of Latin America’s leading healthcare organizations, Seguros SURA Colombia is recognized for its commitment to driving innovation and research that strengthens the healthcare ecosystem. By implementing this cutting-edge liquid biopsy solution for research purposes, SURA is empowering its teams to generate insights that will help advance precision medicine initiatives in Colombia and across the region.

“We are excited to integrate MSK-ACCESS® powered by SOPHiA DDM™ into our Omics Sciences Center. This platform will enable us to deepen our understanding of cancer biology and contribute to the growth of precision medicine in Colombia.” Said Carlos Andrés Agudelo, Manager of the Biosciences Center, Seguros SURA Colombia

At SOPHiA GENETICS, our mission is to democratize data-driven medicine worldwide by giving healthcare and research institutions access to powerful, AI-enabled analytics that transform complex data into meaningful insights. We’re proud to partner with Seguros SURA Colombia as they take this important step toward advancing precision oncology research across the region.

Here’s to expanding access to innovation and accelerating research for better outcomes.

Learn more about MSK-ACCESS® powered with SOPHiA DDM™: https://www.sophiagenetics.com/sophia-ddm-for-genomics/liquid-biopsy/msk-access/

SOPHiA GENETICS is proud to participate in the 50th National Congress of the Mexican Association of Human Genetics (AMGH) and the 9th Latin American Congress of Human Genetics, organized by AMGH and the Red Latinoamericana de Genética Humana.

📅 November 12–14, 2025

📍 Hotel Sheraton Buganvilias, Puerto Vallarta, Jalisco, Mexico

As a global leader in data-driven medicine, we are thrilled to join this milestone event, bringing together experts, researchers, and clinicians from across Latin America.

📍 Visit us at Booth 6

Our team will be on-site to showcase how the SOPHiA DDM™ Platform transforms complex genomic data into actionable insights—empowering healthcare professionals to accelerate discovery, enhance diagnosis, and drive precision medicine forward.

SOPHiA GENETICS is proud to participate in the Congreso Latinoamericano de Patología 2025, taking place in Santiago, Chile.

📍 Visit us at Booth S5

Our team will be on-site to showcase how SOPHiA GENETICS is transforming pathology and laboratory medicine with data-driven insights. Explore our latest innovations across Liquid Biopsy, Solid Tumors, Hematologic Malignancies, and more—empowering clinicians and researchers to advance precision medicine in Latin America.

We look forward to connecting with the pathology community in Santiago and sharing how our technology is shaping the future of healthcare.

We’re excited to be part of the 36th Brazilian Congress of Medical Genetics, joining experts, researchers, and clinicians from Brazil. Our focus this year is on presenting the most recent launch — SOPHiA DDM™ Enhanced Exome Solutions. Visit us at booth #3 to learn how our technology can empower your work in medical genetics.